Navigation Links
It's the Same Old Song: 'Accentuate the Positive' as New York State Department of Health Releases Statewide Hospital Infection Rates
Date:7/8/2008

Statement From the Committee to Reduce Infection Deaths (RID)

NEW YORK, July 8 /PRNewswire-USNewswire/ -- "These are not facts to be proud of," says Betsy McCaughey, Chairman of the Committee to Reduce Infection Deaths and a former Lt. Governor of New York State. The New York State Hospital-Acquired Infection Reporting System 2007 report, released today, constantly compares New York's performance with national infection rate averages, and finds the state slightly below or slightly above these averages. But the only acceptable infection rate is zero. Hospitals that settle for being below average are dangerous places to be. Would you volunteer your mother to get an infection at a hospital with a below average rate?

"For example, central line associated blood stream infections are totally preventable," says McCaughey. Beth Israel Medical Center in New York City hasn't had a central line infection in the cardiac intensive care unit in over 950 days. Not one. Such evidence is why Medicare now considers central line infections 'never events' and will stop reimbursing hospitals to treat them beginning October 1, 2008. Central line infections should never happen.

It is shocking that New York State refuses to follow Medicare's example. New York's Medicaid program for low-income patients continues to pay for treating infections contracted in hospitals, including central line infections. The state is bowing to the hospital lobby rather than protecting patients.

The Department of Health report emphasizes the risk factors that may predispose a patient to succumb to infection, including obesity. But there is no mention of the biggest risk factor of all: being treated in an unclean hospital with lax procedures.

"I founded RID because when I was Lt. Governor, so many people came to me suffering because of a hospital infection. The report's real utility is in reminding hospitals how far they have to go."

RID is a 501c(3) national camp
'/>"/>

SOURCE Committee to Reduce Infection Deaths
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related medicine news :

1. Hanger Orthopedic Group, Inc. Receives Positive Outlook from Standard & Poors Rating Services
2. False Positives in Oral HIV Test Halt Use in NYC
3. PAs First West-Nile-Positive Mosquito of 2008 Season Discovered in Luzerne County
4. PreMD Reports Further Positive Meetings with the FDA
5. Delaying school start time by one hour positively affects adolescents cognitive performance
6. Programs succeed in reducing risky sex among HIV-positive minority men
7. US soldiers in high-tuberculosis areas face new epidemic: false positives
8. New study shows positive role physical therapists play in lymphedema diagnois and treatment
9. Body Positive Marks a New Era With Continued Commitment and a New Name: The Southwest Center for HIV/AIDS
10. Study Finds Nearly One-Third of All Inexpensive Earrings Examined Tested Positive for Nickel
11. Sanofi-aventis: Encouraging First-Quarter 2008 Results Further Positive Phase III Results for Eplivanserin
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/4/2009)... can help prevent pain and injury, doctors say ,...hile baby boomers are not as young as they used to...rtain precautions are in order to stay injury-free...steps to protect themselves from injuries when exe...can Academy of Orthopaedic Surgeons, said in a new...
(Date:7/3/2009)... Reward and recognise service excellence during Na... London (PRWeb UK) July 3, 20...K are being urged to celebrate the importance of e...al Customer Service Week - 5-11 October., , ,Emplo...the corner shop and local authority see the week, ...
(Date:7/3/2009)...divorce or death in middle age may triple the risk...thDay News) -- Middle-aged adults who live alone a...r,s disease later in life compared to those who ar...three times higher among those who are divorced or...Finnish researchers. , The study included 2,000...
(Date:7/3/2009).../PRNewswire-Asia/ -- Sundia MediTech, a leading,i...urcing company in Shanghai,China announced today...,President of Chemistry Services. , Prior ...iosciences, a drug,discovery and development comp...scientist to Senior Director of Medicinal Chemistr...
Breaking Medicine News(10 mins):Health News:Exercise Tips to Keep Boomers on Their Feet 2Health News:Businesses Urged to Sign Up and Celebrate Customer Service 2Health News:Living Alone Increases Odds of Developing Dementia 2Health News:Sundia MediTech Appoints Dr. Chen Chen as Senior VP of Chemistry 2
...e surgical technique involving Botox brings relief...go, Sharon Schafer Bennett suffered from migraines...kept her from seeking a job and interfered with pa...n's daily activities. Now, thanks to an innovativ...
...sophila fruit fly may pave the way to new methods ...ase//, the leading cause of death in industrialize...The study reports that mutations in a molecular ch...anes caused arrhythmias similar to those that are ...
...s are full of pleasant surprises. They don't scrap...isrupted energy flows and prescribe homeopathic re... more traditional-minded colleagues sceptical. Som...ing they all agree on. "We drill just like ordina...
...patients have cholesterol higher than national gui...nted the stroke from happening//, according to a s...ntific journal of the American Academy of Neurolog...lized for stroke or transient ischemic attack (TIA...
Other Medicine News:Health News:A Combination of Botox and Surgery Cures Migraines 2Health News:A Combination of Botox and Surgery Cures Migraines 3Health News:Fruit Flies May Pave Way to New Treatments for Age-related Heart Disease 2Health News:Fruit Flies May Pave Way to New Treatments for Age-related Heart Disease 3Health News:Homeopathy and Hypnosis Come to Dentistry 2Health News:Cholesterol in Stroke Patients Exceeds National Guidelines 2
(Date:6/28/2009)...Newswire-FirstCall/ -- Sangamo BioSciences, Inc. (...ch milestone has been achieved in its Research and...owned member of the Roche Group, for the generatio...rmaceutical protein production purposes using Sang...nuclease (ZFN) technology. Genentech scientists de...
(Date:6/26/2009)...RNewswire-FirstCall/ -- Sanofi-aventis (EURONEXT...f data associated with a retrospective follow-up o...ta clearly show that no definitive conclusions can... between Lantus(R) (insulin glargine [rDNA] inject...e authors of the study point out. , , Clinical ...
(Date:6/25/2009)...xperts Slated to Attend First National Symposium -...e first national symposium designed to explore the... week in New York City when thirteen top experts g...respective fields. The SUNY Youth Sports Institut...th impacts that the $5 billion-a-year energy drink...
(Date:6/25/2009)...a Highlighted at the College on Problems of Drug D... 25 King Pharmaceuticals, Inc. (NY...senting safety and efficacy data for ACUROX(R) a... formulations that are in development, at the 71st... Dependence. King is also developing other pain m...
Breaking Medicine Technology:Sangamo BioSciences Announces Achievement of Key Milestone in Cell Engineering Agreement With Genentech 2Sangamo BioSciences Announces Achievement of Key Milestone in Cell Engineering Agreement With Genentech 3Sanofi-aventis Stands Behind the Safety of Lantus(R) 2Sanofi-aventis Stands Behind the Safety of Lantus(R) 3SUNY Youth Sports Institute Convenes Top Experts in NYC Next Week to Present Research & Analysis on Energy Drink Health Impacts 2SUNY Youth Sports Institute Convenes Top Experts in NYC Next Week to Present Research & Analysis on Energy Drink Health Impacts 3SUNY Youth Sports Institute Convenes Top Experts in NYC Next Week to Present Research & Analysis on Energy Drink Health Impacts 4King Pharmaceuticals Showcases Data From Pain Pipeline of Medicines Designed to Deter Common Methods of Non-Therapeutic Use 2King Pharmaceuticals Showcases Data From Pain Pipeline of Medicines Designed to Deter Common Methods of Non-Therapeutic Use 3King Pharmaceuticals Showcases Data From Pain Pipeline of Medicines Designed to Deter Common Methods of Non-Therapeutic Use 4King Pharmaceuticals Showcases Data From Pain Pipeline of Medicines Designed to Deter Common Methods of Non-Therapeutic Use 5King Pharmaceuticals Showcases Data From Pain Pipeline of Medicines Designed to Deter Common Methods of Non-Therapeutic Use 6Bad sign for global warming 3A Thawing permafrost holds vast carbon pool 4689 1Bad sign for global warming 3A Thawing permafrost holds vast carbon pool 4689 2Bad sign for global warming 3A Thawing permafrost holds vast carbon pool 4689 3NYU American Museum of Natural History receive 241 6 million NSF grant 4686 1NYU American Museum of Natural History receive 241 6 million NSF grant 4686 2Concentric Named Professional Agency of Record for Discovery Labs SURFAXIN 28R 29 7451 1Concentric Named Professional Agency of Record for Discovery Labs SURFAXIN 28R 29 7451 2Unexplored Arctic region to be mapped 4685 1
...- A comparison of,the long-term economic outcomes ...ith symptom management versus symptom,management a...,injection) was the most cost-effective treatment ...s (RRMS). The study provides,the first pharmacoeco...iple sclerosis (MS) therapies that includes long-t...
...irstCall/ --,Nuvelo, Inc. today announced the publ..., a secreted protein currently in preclinical,deve...tent,stimulator of gastrointestinal (GI) epithelia...ents with inflammatory bowel,conditions, including..., entitled "R-Spondin1, A Novel Intestinotrophic M...
Other Medicine Technology:First Pharmacoeconomic Analysis with Long-Term Data Showed Copaxone,Was More Cost-Effective Than Interferon Beta Therapies for,Treatment of Relapsing-Remitting Multiple Sclerosis (RRMS) 2First Pharmacoeconomic Analysis with Long-Term Data Showed Copaxone,Was More Cost-Effective Than Interferon Beta Therapies for,Treatment of Relapsing-Remitting Multiple Sclerosis (RRMS) 3First Pharmacoeconomic Analysis with Long-Term Data Showed Copaxone,Was More Cost-Effective Than Interferon Beta Therapies for,Treatment of Relapsing-Remitting Multiple Sclerosis (RRMS) 4First Pharmacoeconomic Analysis with Long-Term Data Showed Copaxone,Was More Cost-Effective Than Interferon Beta Therapies for,Treatment of Relapsing-Remitting Multiple Sclerosis (RRMS) 5First Pharmacoeconomic Analysis with Long-Term Data Showed Copaxone,Was More Cost-Effective Than Interferon Beta Therapies for,Treatment of Relapsing-Remitting Multiple Sclerosis (RRMS) 6Nuvelo Announces Publication of NU206 Study Results in,Gastroenterology 2Nuvelo Announces Publication of NU206 Study Results in,Gastroenterology 3Nuvelo Announces Publication of NU206 Study Results in,Gastroenterology 4
Cleveland Bone Cutter #5, 17cm, 6-3/4"
Palm Style Impactor Bone Awl with Ortho-Grip® silicone rubber handles and,stainless steel impactor caps.
CapSureSP Novus 5594 is a J-shaped, endocardial, tined pacing lead. provide the stable, low pacing thresholds and large sensing potentials already proven with CapSure SP steroid-eluting leads but wi
The Guidant Fineline II Sterox is a steroid-eluting pacing lead designed for permanent implantation for either atrial or ventricular applications.
Medicine Products: